Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-17-027954

Chief Executive Officer acquired 26,667 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kulkarni Samarth Chief Executive Officer 2017-12-01 Grant or award +26,667 $19.12 $509,873 133,560 D
Derivatives
Kulkarni Samarth Chief Executive Officer 2017-12-01 Grant or award · Stock Option (Right to Buy) +260,000 260,000 D
Loading xslF345X03/doc4.xml…